Charles S. Berkman, VP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 28,323 shares at $47.54 ($1.3M) on 2013-08-30, disclosed to the SEC on 2013-09-04.
Open-market sale of $1.3M LGND by VP, General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.54 | 7,020 | $334K | 24.8% |
| 2 | $47.54 | 9,499 | $452K | 33.5% |
| 3 | $47.54 | 11,804 | $561K | 41.7% |
| Total | $47.54 avg | 28,323 | $1.3M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |